Total planned funding: $541,506,989
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $227,351,834 |
Zambia | $64,089,069 |
Kenya | $52,168,993 |
Mozambique | $37,322,472 |
Vietnam | $32,100,044 |
Tanzania | $21,227,292 |
South Africa | $19,410,453 |
Rwanda | $12,626,915 |
Côte d'Ivoire | $8,821,571 |
Botswana | $8,379,720 |
Haiti | $7,595,000 |
Democratic Republic of the Congo | $6,790,245 |
Papua New Guinea | $6,494,909 |
Uganda | $6,133,638 |
Cambodia | $4,728,160 |
Guyana | $4,375,000 |
India | $4,048,700 |
Ethiopia | $3,198,267 |
Ghana | $2,750,000 |
Angola | $2,250,000 |
China | $1,985,110 |
South Sudan | $1,700,000 |
Namibia | $1,660,293 |
Eswatini | $1,620,000 |
Burundi | $917,000 |
Malawi | $500,000 |
Thailand | $407,304 |
Indonesia | $405,000 |
Lesotho | $250,000 |
Dominican Republic | $200,000 |
Caribbean Region | $0 |
Organizational Types
NGO | $541,506,989 |
Program Areas
Treatment | $145,475,588 |
Care | $143,211,811 |
Prevention | $120,682,448 |
Governance and Systems | $47,108,171 |
Testing | $30,182,971 |
Budget Codes
HTXS: Treatment: Adult Treatment | $113,231,157 |
HBHC: Care: Adult Care and Support | $62,363,659 |
HKID: Care: Orphans and Vulnerable Children | $60,427,374 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $51,178,902 |
HVOP: Sexual Prevention: Other Sexual Prevention | $42,624,246 |
HVCT: Testing: HIV Testing and Counseling | $30,182,971 |
HLAB: Laboratory Infrastructure | $20,836,258 |
HTXD: Treatment: ARV Drugs | $16,910,934 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $16,229,459 |
PDTX: Treatment: Pediatric Treatment | $15,333,497 |
HVSI: Strategic Information | $13,331,974 |
OHSS: Health Systems Strengthening | $12,939,939 |
HVTB: Care: TB/HIV | $12,254,214 |
PDCS: Care: Pediatric Care and Support | $8,166,564 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $7,163,486 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $2,837,533 |
HMIN: Biomedical Prevention: Injection Safety | $503,793 |
HMBL: Biomedical Prevention: Blood Safety | $145,029 |